tiprankstipranks
Trending News
More News >
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX

SkinBioTherapeutics (SBTX) Revenue

Compare
24 Followers

SkinBioTherapeutics Revenue

SkinBioTherapeutics had a revenue of 3.06M in the quarter ending Jun 30, 2024, with 94.14%. This bring the company's revenue in the last twelve months to 4.64M, Decreased 73.15%. In the fiscal year ending Jun 30, 2024, SkinBioTherapeutics had annual revenue of 4.64M with 283.63% growth.
Revenue (ttm)
4.64M
Revenue Growth
283.74%
P/S Ratio
3.91
Revenue/Employee
£309,210
Employees
15
Market Cap
£18.14M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2024
4.64M3.43M+283.63%
Jun 30, 2023
1.21M1.08M+815.51%
Jun 30, 2022
132.06K57.30K+76.64%
Jun 30, 2021
74.76K+∞%
Jun 30, 2020
Jun 30, 2019
Jun 30, 2018
Jun 30, 2018